Conditioned medium from human amniotic mesenchymal stromal cells limits infarct size and enhances angiogenesis

Stem Cells Translational Medicine

Volumn 4, Issue 5, 2015, Pages 448-458

  Danieli, Patrizia ^a,b   Malpasso, Giuseppe ^a,b,c   Ciuffreda, Maria Chiara ^a,b   Cervio, Elisabetta ^a,b   Calvillo, Laura ^d   Copes, Francesco ^a,b   Pisano, Federica ^a,b   Mura, Manuela ^a,b   Kleijn, Lennaert ^e   De Boer, Rudolf A ^e   Viarengo, Gianluca ^f   Rosti, Vittorio ^g   Spinillo, Arsenio ^h   Roccio, Marianna ^h   Gnecchi, Massimiliano ^a,b,c,i  

^a Department of Cardiothoracic and Vascular Sciences Coronary Care Unit and Laboratory of Clinical and Experimental Cardiology   (Italy)

^b Laboratory of Experimental Cardiology for Cell and Molecular Therapy   (Italy)

^c UNIVERSITY OF PAVIA   (Italy)

^d ISTITUTO AUXOLOGICO ITALIANO   (Italy)

^e UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^f Division of Clinical Immunology Immunohematology and Transfusion Service   (Italy)

^g Biotechnology Laboratory   (Italy)

^h FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

ⁱ UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

Cardiac; Clinical translation; Fetal stem cells; Placenta

Indexed keywords

CASPASE 3; MIDKINE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; OSTEONECTIN; CARDIOTONIC AGENT; CULTURE MEDIUM;

AMNIOTIC FLUID STEM CELL; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CAPILLARY DENSITY; CELL MIGRATION; CELL PROTECTION; CELL VIABILITY; CONTROLLED STUDY; CULTURE MEDIUM; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION; HEART INFARCTION SIZE; HEART MUSCLE CELL; HEART VENTRICLE REMODELING; HUMAN; HUMAN CELL; MALE; MESENCHYMAL STROMA CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUNEL ASSAY; UPREGULATION; AMNION FLUID; ANIMAL; BIOLOGICAL THERAPY; CYTOLOGY; DRUG EFFECTS; METABOLISM; MYOCARDIAL INFARCTION; PATHOLOGY; PHARMACOLOGY;

RATTUS;

AMNIOTIC FLUID; ANIMALS; CARDIOTONIC AGENTS; CELL- AND TISSUE-BASED THERAPY; CULTURE MEDIA, CONDITIONED; HUMANS; MESENCHYMAL STROMAL CELLS; MYOCARDIAL INFARCTION; NEOVASCULARIZATION, PHYSIOLOGIC; RATS;

EID: 84930462881     PISSN: 21576564     EISSN: 21576580     Source Type: Journal    
DOI: 10.5966/sctm.2014-0253     Document Type: Article

References (34)

1. Anversa P, Kajstura J, Rota M et al. Regenerating new heart with stem cells. J Clin Invest 2013;123:62–70.
2. Gnecchi M, Danieli P, Cervio E. Mesenchy-mal stem cell therapy for heart disease. Vascul Pharmacol 2012;57:48–55.
3. Noiseux N, Gnecchi M, Lopez-Ilasaca M et al. Mesenchymal stem cells overexpressing Akt dramatically repair infarcted myocardium and improve cardiac function despite infrequent cellular fusion or differentiation. Mol Ther 2006;14:840–850.
4. Gnecchi M, Zhang Z, Ni A et al. Paracrine mechanisms in adult stem cell signaling and therapy. Circ Res 2008;103:1204–1219.
5. Gnecchi M, He H, Liang OD et al. Para-crine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nat Med 2005;11: 367–368.
6. Gnecchi M, He H, Noiseux N et al. Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement. FASEB J 2006;20:661–669.
7. Kinnaird T, Stabile E, Burnett MS et al. Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arte-riogenesis through paracrine mechanisms. Circ Res 2004;94:678–685.
8. Gnecchi M, He H, Melo LG et al. Early beneficial effects of bone marrow-derived mesen-chymal stem cells overexpressing Akt on cardiac metabolism after myocardial infarction. Stem Cells 2009;27:971–979.
9. Hatzistergos KE, Quevedo H, Oskouei BN et al. Bone marrow mesenchymal stem cells stimulate cardiac stem cell proliferation and differentiation. Circ Res 2010;107:913–922.
10. In’t Anker PS, Scherjon SA, Kleijburg-van der Keur C et al. Isolation of mesenchymal stem cellsoffetalormaternal origin from human placenta. Stem Cells 2004;22:1338–1345.
11. Portmann-Lanz CB, Schoeberlein A, HuberAetal. Placental mesenchymal stemcells as potential autologous graft for pre- and perinatal neuroregeneration. Am J Obstet Gynecol 2006;194:664–673.
12. Sakuragawa N, Kakinuma K, Kikuchi A et al. Human amnion mesenchyme cells express phenotypes of neuroglial progenitor cells. J Neurosci Res 2004;78:208–214.
13. Tsuji H, Miyoshi S, Ikegami Y et al. Xeno-grafted human amniotic membrane-derived mesenchymal stem cells are immunologically tolerated and transdifferentiated into cardio-myocytes. Circ Res 2010;106:1613–1623.
14. Edgar R, Domrachev M, Lash A E. GeneEx-pression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res 2002;30:207–210.
15. Sumida A, Horiba M, Ishiguro H et al. Mid-kine gene transfer after myocardial infarction in rats prevents remodelling and ameliorates cardiac dysfunction. Cardiovasc Res 2010;86: 113–121.
16. McCurdy S, Baicu CF, Heymans S et al. Cardiac extracellular matrix remodeling: Fibril-lar collagens and secreted protein acidic and rich in cysteine (SPARC). J Mol Cell Cardiol 2010;48:544–549.
17. Go AS, Mozaffarian D, Roger VL et al. Heart disease and stroke statistics—2013 Update: A report from the American Heart Association. Circulation 2013;127:e6–e245.
18. Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC), Steg PG, James SK et al. ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 2012;33:2569–2619.
19. Heusch G, Musiolik J, Gedik Net al. Mito-chondrial STAT3 activation and cardioprotec-tion by ischemic postconditioning in pigs with regional myocardial ischemia/reperfusion. Circ Res 2011;109:1302–1308.
20. Heusch G. Cardioprotection: Chances and challenges of its translation to the clinic. Lancet 2013;381:166–175.
21. Jakob P, DoerriesC,BriandSet al. Loss of angiomiR-126 and 130ainangiogenic early outgrowth cells from patients with chronic heart failure:Role for impairedinvivo neovasculariza-tion and cardiac repair capacity. Circulation 2012;126:2962–2975.
22. Kawamoto A, Murayama T, Kusano K et al. Synergistic effect of bone marrow mobilization and vascular endothelial growth factor-2 gene therapy in myocardial ischemia. Circulation 2004;110:1398–1405.
23. Yanagisawa-Miwa A, Uchida Y, Naka-mura F et al. Salvage of infarcted myocardium by angiogenic action of basic fibroblast growth factor. Science 1992;257:1401–1403.
24. Horiba M, Kadomatsu K, Yasui K et al. Midkine plays a protective role against cardiac ischemia/reperfusion injury through a reduction of apoptotic reaction. Circulation 2006; 114:1713–1720.
25. Takenaka H, Horiba M, Ishiguro H et al. Midkine prevents ventricular remodeling and improves long-term survival after myocardial infarction. Am J Physiol Heart Circ Physiol 2009;296:H462–H469.
26. Kadomatsu K, Bencsik P, Görbe A et al. Therapeutic potential of midkine in cardiovascular disease. Br J Pharmacol 2014;171:936–944.
27. Schellings MW, Vanhoutte D, Swinnen M et al. Absence of SPARC results in increased cardiac rupture and dysfunction after acute myocardial infarction. J Exp Med 2009;206: 113–123.
28. Lai RC, Arslan F, Lee MM et al. Exosome secreted by MSC reduces myocardial ischemia/ reperfusion injury. Stem Cell Res (Amst) 2010; 4:214–222.
29. Martinez MC, Andriantsitohaina R. Microparticlesin angiogenesis: Therapeutic potential. Circ Res 2011;109:110–119.
30. Ailawadi S, Wang X, Gu H et al. Pathologic function and therapeutic potentialofexosomes in cardiovascular disease. Biochim Biophys Acta 2015;1852:1–11.
31. Timmers L, Lim SK, Hoefer I E et al. Human mesenchymal stem cell-conditioned medium improves cardiac function following myocar-dial infarction. Stem Cell Res (Amst) 2011;6: 206–214.
32. Mangi AA, Noiseux N, Kong D et al. Mes-enchymal stem cells modified with Akt prevent remodeling and restore performance of in-farcted hearts. Nat Med 2003;9:1195–1201.
33. Matsumoto R, Omura T, Yoshiyama M et al. Vascular endothelial growth factor-expressing mesenchymal stem cell transplantation for the treatment of acute myocardial infarction. Arterioscler Thromb Vasc Biol 2005; 25:1168–1173.
34. Tang YL, Tang Y,Zhang YC etal. Improved graft mesenchymal stem cell survival in ische-mic heart with a hypoxia-regulated heme oxygenase-1 vector. J Am Coll Cardiol 2005; 46:1339–1350.